Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-01-02 @ 1:17 PM
Study NCT ID:
NCT00701103
Status:
COMPLETED
Last Update Posted:
2018-08-08
First Post:
2008-06-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)
Sponsor:
Organization: